Search results
Why Is Novavax (NVAX) Stock Up 20% Today?
InvestorPlace· 2 hours agoNovavax (NASDAQ:NVAX) is on a recovery trek after collapsing in late 2021. Regarding timeline, the latter two firms said that they would be able to...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 7 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via AOL· 10 hours ago(Reuters) -Advisers to the U.S. Food and Drug Administration on Wednesday unanimously voted in favor...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
FDA advisers: Next COVID shots should target variants with JN.1 lineage | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 13 hours agoAdvisers to the U.S. Food and Drug Administration today unanimously voted in favor of recommending...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 days agoLorbrena, like Pfizer's Xalkori, is designed to treat cancer with a mutation of a specific gene...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 9 hours agoCOVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 5 hours agoNovavax, Inc. NVAX shares are trading higher Wednesday, and the stock is up by more than 300% over...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal cancer. The vaccine...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 5 days agoThe FDA recently delayed its decision on the Moderna vaccine to the end of the month. If approved,...
